3-50402995-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006030.4(CACNA2D2):​c.406-8827T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.289 in 151,938 control chromosomes in the GnomAD database, including 8,905 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 8905 hom., cov: 32)

Consequence

CACNA2D2
NM_006030.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.966

Publications

7 publications found
Variant links:
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
CACNA2D2 Gene-Disease associations (from GenCC):
  • cerebellar atrophy with seizures and variable developmental delay
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.532 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA2D2NM_006030.4 linkc.406-8827T>C intron_variant Intron 3 of 37 ENST00000424201.7 NP_006021.2 Q9NY47-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA2D2ENST00000424201.7 linkc.406-8827T>C intron_variant Intron 3 of 37 1 NM_006030.4 ENSP00000390329.2 Q9NY47-2
CACNA2D2ENST00000423994.6 linkc.406-8827T>C intron_variant Intron 3 of 38 5 ENSP00000407393.2 C9JVC9
CACNA2D2ENST00000266039.7 linkc.406-8827T>C intron_variant Intron 3 of 37 1 ENSP00000266039.3 Q9NY47-3
CACNA2D2ENST00000360963.7 linkc.199-8827T>C intron_variant Intron 3 of 37 1 ENSP00000354228.3 Q9NY47-4

Frequencies

GnomAD3 genomes
AF:
0.288
AC:
43797
AN:
151818
Hom.:
8864
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.538
Gnomad AMI
AF:
0.151
Gnomad AMR
AF:
0.390
Gnomad ASJ
AF:
0.0888
Gnomad EAS
AF:
0.474
Gnomad SAS
AF:
0.130
Gnomad FIN
AF:
0.156
Gnomad MID
AF:
0.156
Gnomad NFE
AF:
0.146
Gnomad OTH
AF:
0.240
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.289
AC:
43888
AN:
151938
Hom.:
8905
Cov.:
32
AF XY:
0.288
AC XY:
21429
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.538
AC:
22273
AN:
41392
American (AMR)
AF:
0.390
AC:
5951
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.0888
AC:
308
AN:
3470
East Asian (EAS)
AF:
0.474
AC:
2441
AN:
5146
South Asian (SAS)
AF:
0.129
AC:
624
AN:
4822
European-Finnish (FIN)
AF:
0.156
AC:
1648
AN:
10566
Middle Eastern (MID)
AF:
0.143
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
0.146
AC:
9956
AN:
67966
Other (OTH)
AF:
0.241
AC:
508
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1336
2672
4008
5344
6680
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
392
784
1176
1568
1960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.245
Hom.:
877
Bravo
AF:
0.322
Asia WGS
AF:
0.291
AC:
1012
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.7
DANN
Benign
0.71
PhyloP100
-0.97
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2236957; hg19: chr3-50440426; API